[go: up one dir, main page]

PL1694320T3 - Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności - Google Patents

Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności

Info

Publication number
PL1694320T3
PL1694320T3 PL04806247T PL04806247T PL1694320T3 PL 1694320 T3 PL1694320 T3 PL 1694320T3 PL 04806247 T PL04806247 T PL 04806247T PL 04806247 T PL04806247 T PL 04806247T PL 1694320 T3 PL1694320 T3 PL 1694320T3
Authority
PL
Poland
Prior art keywords
acid
hypersensitivity
treatment
hyperreactivity
medicament
Prior art date
Application number
PL04806247T
Other languages
English (en)
Inventor
Frederick W Cain
Wiro Stam
Ulrike Schmid
Geoff Collins
Original Assignee
Lipid Nutrition Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipid Nutrition Bv filed Critical Lipid Nutrition Bv
Publication of PL1694320T3 publication Critical patent/PL1694320T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL04806247T 2003-12-19 2004-12-17 Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności PL1694320T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03258087 2003-12-19
EP04806247A EP1694320B1 (en) 2003-12-19 2004-12-17 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity
PCT/GB2004/005453 WO2005058302A1 (en) 2003-12-19 2004-12-17 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity

Publications (1)

Publication Number Publication Date
PL1694320T3 true PL1694320T3 (pl) 2008-11-28

Family

ID=34684630

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04806247T PL1694320T3 (pl) 2003-12-19 2004-12-17 Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności

Country Status (9)

Country Link
US (1) US20110229563A1 (pl)
EP (1) EP1694320B1 (pl)
JP (1) JP2007514727A (pl)
CN (1) CN1893937B (pl)
AT (1) ATE400262T1 (pl)
DE (1) DE602004014974D1 (pl)
ES (1) ES2311177T3 (pl)
PL (1) PL1694320T3 (pl)
WO (1) WO2005058302A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6453538B2 (ja) * 2010-11-22 2019-01-16 フェニックス・バイオテクノロジー・インコーポレイテッド キョウチクトウ属の種又はテベティア属の種の抽出物で神経学的状態を治療する方法
CN111557432B (zh) 2013-02-08 2023-08-04 通用磨坊公司 低钠食品
KR101645963B1 (ko) * 2014-05-13 2016-08-08 주식회사한국야쿠르트 사과박(apple pomace)으로부터 우르솔릭산을 고효율로 추출하는 방법 및 그 방법에 의해 추출된 우르솔릭산을 유효성분으로 함유하는 식품조성물
CN104610417B (zh) * 2015-02-16 2016-05-11 白心亮 一种从山楂中提取熊果酸和齐墩果酸的方法
EP3681477A4 (en) * 2017-09-14 2021-06-09 Phoenix Biotechnology, Inc. PROCEDURES AND IMPROVED COMPOSITION FOR TREATMENT OF TREITERPEN RESPONSIBLE CONDITIONS, DISEASES, OR DISORDERS
DE102018217341A1 (de) 2018-10-10 2020-04-16 Katjes Fassin GmbH.+Co. Kommanditgesellschaft Mit apfelwachs beschichtetes bonbon
JP7276745B2 (ja) * 2019-06-14 2023-05-18 地方独立行政法人青森県産業技術センター リンゴ由来トリテルペノイド含有組成物製造方法、ウルソール酸製造方法、およびオレアノール酸製造方法
CN112704663B (zh) * 2020-12-18 2022-07-19 吉林农业科技学院 一种枇杷叶熊果酸乳膏的制备方法
CN114129572B (zh) * 2021-12-16 2023-04-07 南开大学 一种协同抑制汉防己甲素诱导的药源性肝损伤的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03287530A (ja) * 1990-03-31 1991-12-18 Snow Brand Milk Prod Co Ltd 免疫抑制剤
JPH1112178A (ja) * 1997-06-23 1999-01-19 Dainippon Pharmaceut Co Ltd オレアノール酸系抗掻痒剤
DE60114708T2 (de) * 2000-06-05 2006-07-20 Loders Croklaan B.V. Ursolsäure und Oleanolsäure enthaltende Mischungen
ATE295087T1 (de) * 2001-04-09 2005-05-15 Loders Croklaan Bv Konzentrat von triterpenen
JP5081354B2 (ja) * 2001-11-07 2012-11-28 株式会社ナリス化粧品 IgE産生抑制剤

Also Published As

Publication number Publication date
ES2311177T3 (es) 2009-02-01
CN1893937B (zh) 2011-01-12
ATE400262T1 (de) 2008-07-15
EP1694320A1 (en) 2006-08-30
DE602004014974D1 (de) 2008-08-21
US20110229563A1 (en) 2011-09-22
EP1694320B1 (en) 2008-07-09
WO2005058302A1 (en) 2005-06-30
JP2007514727A (ja) 2007-06-07
CN1893937A (zh) 2007-01-10

Similar Documents

Publication Publication Date Title
EP4533963A3 (en) Moist oral compositions
NZ586759A (en) Aqueous-alcoholic, single-phase transcutaneous pharmaceutical compositions containing a steroid hormone
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
MY159379A (en) Composition for human and/or animal nutrition, uses thereof and yeasts
EP3434687A3 (en) Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
ATE444738T1 (de) Verbesserte essbare filmformulierungen mit maltodextrin
WO2006127690A3 (en) Delivery systems for managing release of sensates in an edible composition
WO2008118017A3 (en) Prame derived peptides and immunogenic compositions comprising these
MY143795A (en) Tetrahydropyridoindole derivatives
WO2002083879A3 (en) Immunotherapy based on dendritic cells
WO2000053149A3 (en) Method and composition for administering a cyclooxygenase-2 inhibitor
PL1694320T3 (pl) Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności
WO2008100907A3 (en) Fluoride-releasing compositions
IL192611A0 (en) Biologically active composition comprising ethylcellulose
HK1245086A1 (zh) 处方药物组成及其制备和使用
WO2007064968A3 (en) Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
UA95224C2 (ru) Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
WO2007010084A3 (en) Immunostimulatory oligo- and polysaccharides and uses thereof
WO2004034813A3 (en) Composition for reducing caloric intake
EP1269991A3 (en) Composition for topical use based on the ethylic ester of linoleic acid and on the triethyl ester of citric acid associated with suitable synergists
EP4327815A3 (en) Probiotics for regulating blood glucose
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
SI1651194T1 (sl) Stabilni farmacevtski sestavki za nadzorovano sproščanje, ki vsebujejo fenofibrat in pravastatin
EP1550443A4 (en) COMPOSITION AGAINST STRESS-BASED DISEASES